Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment.

Baronikova S, Purvis J, Southam E, Beeso J, Panayi A, Winchester C.

BMJ Evid Based Med. 2019 Oct;24(5):177-184. doi: 10.1136/bmjebm-2018-111145. Epub 2019 Mar 21.

2.

An ex-vivo angiogenesis assay as a screening method for natural compounds and herbal drug preparations.

Baróniková S, Apers S, Vanden Berghe D, Cos P, Vermeulen P, Van Daele A, Pieters L, Van Marck E, Vlietinck A.

Planta Med. 2004 Oct;70(10):887-92.

PMID:
15490313
3.

Antiangiogenic activity of synthetic dihydrobenzofuran lignans.

Apers S, Paper D, Bürgermeister J, Baronikova S, Van Dyck S, Lemière G, Vlietinck A, Pieters L.

J Nat Prod. 2002 May;65(5):718-20.

PMID:
12027748
4.

[Constituents of the leaves of Ligustrum delavayanum Hariot].

Nagy M, Baróniková S, Grancai D, Mucaji P.

Ceska Slov Farm. 2001 Nov;50(6):283-5. Slovak. Erratum in: Ceska Slov Farm 2002 Mar;51(2):103.

PMID:
11797198
5.

The effect of Ligustrum delavayanum on isolated perfused rat heart.

Stankovicová T, Frýdl M, Kubicová M, Baróniková S, Nagy M, Grancai D, Svec P.

Exp Clin Cardiol. 2001 Fall;6(3):132-6.

6.

Antiviral, haemolytic and molluscicidal activities of triterpenoid saponins from Maesa lanceolata: establishment of structure-activity relationships.

Apers S, Baronikova S, Sindambiwe JB, Witvrouw M, De Clercq E, Vanden Berghe D, Van Marck E, Vlietinck A, Pieters L.

Planta Med. 2001 Aug;67(6):528-32.

PMID:
11509973
7.

Supplemental Content

Loading ...
Support Center